Resignation of Portfolio Managers

Summary by AI ^BETAClose X

Geiger Counter Limited announced that its two co-portfolio managers have resigned from Manulife CQS Investment Management, and are currently serving their three-month notice periods. The company's board does not anticipate immediate disruption to its investment process or operations and is evaluating future portfolio management arrangements, with a further announcement expected in due course.

Disclaimer*

Geiger Counter Ltd

09 March 2026

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED

Geiger Counter Limited (or the "Company")

09 March 2026

Portfolio Management arrangements

The Board of the Company has been notified that the Company's two co-portfolio managers, Keith Watson and Rob Crayfourd (together the "Co-Managers"), have resigned from Manulife CQS Investment Management ("Manulife CQS").

The Co-Managers are serving their [three]‑month notice periods at Manulife CQS. The Board does not expect any immediate disruption to its investment process or operations.

The Board is considering its options regarding future portfolio management arrangements and will make a further announcement in due course.

Enquiries

Manulife CQS Investment Management	Craig Cleland	T: +44 (0) 20 7201 5368]
Cavendish Capital Markets Limited	Tunga Chigovanyika (Corporate Finance)	T: +44 (0) 20 7397 1915
	Daniel Balabanoff / Pauline Tribe (Sales)	T: +44 (0) 20 7220 0500
Summit Fund Services Jersey Limited	Christopher Foulds	T :+44 (0) 1534 825 259

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END